Menu
Close
Our association is aiming to support children and families affected by MECP2 duplication syndrome, a rare, severe and progressive genetic disease.
Our missions are dedicated to: support families, inform about scientific advances, fund research projects.
Our association is aiming to support children and families affected by MECP2 duplication syndrome, a rare, severe and progressive genetic disease.
Our missions are dedicated to: support families, inform about scientific advances, fund research projects.
MECP2 gene duplication syndrome is a rare and severe genetic disorder. The syndrome is mainly characterized by intellectual disability, hypotonia, lack of speech and seizures. The symptoms and their intensity vary from child to child.
Our association is aiming to raise awareness on rare diseases, identify projects and participate in their funding and support and inform families to enhance quality of live for children with MECP2 duplication syndrome.
Contribute to projects to advance research, support families, improve care, or help the development of our association.
Clinical research needs all patients with MECP2 duplication syndrome in order to gather as much information as possible about this rare disease. There are several registries where people with MECP2 duplication syndrome can be registered to increase knowledge about MECP2 and to advance drug research.
We are proud to be one of the 48 patient organisations and advocacy groups working in the field of rare diseases in Germany and Austria, which are once again joining forces […]
On Saturday 19 December 2026, from 5.00 pm, we will be running a coffee and cake stall at the Gramatneusiedl community centre. As part of this much-loved tradition, organised under the […]
On 14 and 15 November 2026, we will once again be running our mulled wine stall in Gramatneusiedl. With delicious mulled wine and a selection of culinary specialities, we invite you […]
This important event will enable MECP2 gene duplication syndrome specialists, scientists and families to meet and discuss current developments in the field of gene therapy.
Subscribe to out newsletter to stay informed about our actions and scientific advances on the syndrome